Sonoma Pharmaceuticals
SNOA
#10418
Rank
S$6.22 M
Marketcap
S$3.60
Share price
-3.40%
Change (1 day)
13.17%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2025 (TTM): -S$4.11 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are S$16.93 Million. In 2024 the company made an earning of -S$5.66 Million a decrease over its 2023 earnings that were of -S$5.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$4.11 Million-27.32%
2024 -S$5.66 Million0.54%
2023 -S$5.63 Million-31.5%
2022 -S$8.21 Million16.86%
2021 -S$7.03 Million194.32%
2020 -S$2.39 Million-58.76%
2019 -S$5.79 Million-65.66%
2018 -S$16.86 Million4.84%
2017 -S$16.08 Million-2.17%
2016 -S$16.44 Million32.12%
2015 -S$12.44 Million-307.74%
2014 S$5.98 M-197.5%
2013 -S$6.14 Million
2010 -S$9.6 Million-14.02%
2009 -S$11.16 Million-57.28%
2008 -S$26.12 Million-8.03%
2007 -S$28.4 Million3.85%
2006 -S$27.35 Million39.31%
2005 -S$19.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion 5,013.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23 Million 482.11%๐Ÿ‡บ๐Ÿ‡ธ USA